COMMUNIQUÉS West-GlobeNewswire

IRIDEX Announces Appointment of Robert E. Grove, Ph.D. to its Board of Directors
15/10/2018
MOUNTAIN VIEW, Calif., Oct. 15, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today announced the appointment of Dr. Robert Grove to the Company’s Board of Directors effective October 15, 2018. Concurrently [...]
Savara Completes Enrollment in Pivotal Molgradex Impala Clinical Study for the Treatment of aPAP
15/10/2018
Top Line Results Expected in Q2 2019 AUSTIN, Texas, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Savara Inc. (Nasdaq: SVRA), an orphan lung disease company, today announced completion of the target enrollment of 135 patients in [...]
Tyme Appoints Former Kite and Celgene Executive, Michele Korfin, as Chief Commercial Officer
15/10/2018
NEW YORK, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies Inc, (Nasdaq: TYME), a clinical stage biotechnology company developing cancer therapeutics to address multiple tumor types, today announced the appointment [...]
CTD Holdings Announces Plans to Broaden its Expanded Access Program for Trappsol® Cyclo™
15/10/2018
Company expects to provide its drug to new patients in early 2019 ALACHUA, Fla., Oct. 15, 2018 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin- [...]
Delcath Expands Rollout of Registration Trial in Metastatic Ocular Melanoma
15/10/2018
Seven Cancer Centers in United States Open for Enrollment in Amended Trial NEW YORK, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of [...]
Krystal Biotech Announces Positive Interim Results from Placebo-Controlled Phase 1/2 Clinical Trial of KB103
15/10/2018
KB103 is Krystal’s first "off-the-shelf", topical, gene therapy candidate to treat patients suffering from Dystrophic Epidermolysis Bullosa. Results on 2 patients met all primary efficacy (presence of functional COL7 [...]
GUERBET : Information sur les opération effectuées dans le cadre du programme de rachat d'actions
15/10/2018
Villepinte (France), le 15 octobre 2018 Le présent document a pour finalité de présenter les opérations réalisées dans le cadre du programme de rachat d'actions autorisé par l'Assemblée Générale Mixte du 25 mai 2018 sur [...]
PacBio Long-Read Sequencing Featured at ASHG Annual Meeting
15/10/2018
Highlights include release of new chemistry and more than 25 presentations demonstrating utility of SMRT Sequencing for human genetics applications MENLO PARK, Calif., Oct. 15, 2018 (GLOBE NEWSWIRE) -- Pacific [...]
Retrotope Presents Data Demonstrating Arrest of Disease Progression with Treatment of RT001 in Patients with Infantile Neuroaxonal Dystrophy (INAD)
15/10/2018
Results presented at the 2018 National Organization for Rare Disorders (NORD) Rare Diseases & Orphan Products Breakthrough Summit® LOS ALTOS, Calif., Oct. 15, 2018 (GLOBE NEWSWIRE) -- Retrotope today reported new [...]
Theratechnologies Appoints New Board Member
15/10/2018
MONTREAL, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced the appointment of Mr. Gary Littlejohn as a new independent member to its Board of Directors. “Gary brings [...]
Theratechnologies nomme un nouveau membre à son conseil d’administration
15/10/2018
MONTRÉAL, 15 oct. 2018 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Société) (TSX: TH) a annoncé aujourd’hui la nomination de M. Gary Littlejohn à titre d’administrateur indépendant du conseil d’administration de la [...]
Apotheca Biosciences (PCFP) Announces Addition of Dr. Mali Reddy, Seven Time Nobel Prize Nominee, as Chief Medical Adviser & Medical Researcher
15/10/2018
SAINT PETERSBURG, FL, Oct. 15, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Apotheca Biosciences (OTC PINK: PCFP), a developer of cutting-edge medical products, nutraceuticals, drug formulations and cannabis delivery [...]
EDAP TMS SA : EDAP Announces Expiration of Tranche of Outstanding Warrants
15/10/2018
Warrants for Approximately 3.3 Million Ordinary Shares in the Form of American Depository Shares Expired on October 14, 2018 LYON, France, October 15, 2018 -- EDAP TMS SA (Nasdaq: EDAP) ("the Company"), the global [...]
XORTX Announces New Clinical Advisory Board Members
15/10/2018
CALGARY, Alberta, Oct. 15, 2018 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (" XORTX " or the “ Company ”) (CSE:XRX; OTCQB:XRTXF), a biopharmaceutical company focused on developing innovative therapies to treat [...]
Athenex and Xiangxue Life Sciences Announce Preliminary Results of Patients Receiving T-Cell Receptor Affinity Enhancing Specific T-Cell Therapy (TAEST) Showed Encouraging Positive Clinical Signals
15/10/2018
BUFFALO, N.Y., Oct. 15, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (NASDAQ:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
Aravive Biologics and Versartis Complete Merger
15/10/2018
The combined company, Aravive, Inc., to trade on Nasdaq under ticker symbol “ARAV” beginning October 16, 2018, concurrent with a 1-for-6 reverse split of common shares HOUSTON, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Aravive [...]
Loxo Oncology Announces Receipt of Breakthrough Therapy Designation from U.S. Food and Drug Administration for LOXO-292 for the Treatment of RET Fusion-Positive Thyroid Cancer
15/10/2018
STAMFORD, Conn., Oct. 15, 2018 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical company developing highly selective medicines for patients with genomically defined cancers, today announced that [...]
EyePoint Pharmaceuticals Receives FDA Approval of YUTIQ™ (fluocinolone acetonide intravitreal implant) 0.18 mg
15/10/2018
- The first long-lasting, FDA approved micro-insert for up to three years of continuous control in chronic, non-infectious posterior segment uveitis, the third leading cause of blindness in the U.S. - Company to host [...]
Tetra Bio-Pharma Names Dr. Guy Chamberland as Chief Executive Officer and Chief Scientific Officer
15/10/2018
ORLEANS, Ontario, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc ., a leader in cannabinoid-based drug discovery and development (TSX VENTURE: TBP) (OTCQB: TBPMF), today announced the permanent appointment of [...]

Pages